PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 201 filers reported holding PTC THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,247,780 | -12.7% | 635,778 | +58.5% | 0.01% | 0.0% |
Q2 2023 | $16,316,234 | +315.6% | 401,186 | +395.0% | 0.01% | +400.0% |
Q1 2023 | $3,926,304 | +98.0% | 81,055 | +56.0% | 0.00% | 0.0% |
Q4 2022 | $1,983,000 | +126.4% | 51,944 | +197.4% | 0.00% | – |
Q3 2022 | $876,000 | +22.9% | 17,468 | -1.8% | 0.00% | – |
Q2 2022 | $713,000 | +6.1% | 17,789 | -1.3% | 0.00% | – |
Q1 2022 | $672,000 | +20.2% | 18,018 | +52.6% | 0.00% | – |
Q1 2021 | $559,000 | -66.8% | 11,807 | -57.2% | 0.00% | -100.0% |
Q4 2020 | $1,685,000 | -13.0% | 27,612 | -33.4% | 0.00% | 0.0% |
Q3 2020 | $1,937,000 | -34.2% | 41,440 | -28.5% | 0.00% | 0.0% |
Q2 2020 | $2,942,000 | +27.2% | 57,990 | +11.9% | 0.00% | 0.0% |
Q1 2020 | $2,313,000 | +18.7% | 51,845 | +27.8% | 0.00% | 0.0% |
Q4 2019 | $1,949,000 | +43.9% | 40,575 | +1.4% | 0.00% | 0.0% |
Q3 2019 | $1,354,000 | -38.6% | 40,031 | -18.3% | 0.00% | 0.0% |
Q2 2019 | $2,205,000 | -40.8% | 49,011 | -50.5% | 0.00% | -50.0% |
Q1 2019 | $3,724,000 | +8.3% | 98,926 | -1.3% | 0.00% | 0.0% |
Q4 2018 | $3,440,000 | +296.8% | 100,259 | +289.7% | 0.00% | – |
Q2 2018 | $867,000 | +26.0% | 25,724 | +1.2% | 0.00% | – |
Q1 2018 | $688,000 | +58.5% | 25,412 | -2.2% | 0.00% | – |
Q4 2017 | $434,000 | -72.9% | 25,996 | -67.5% | 0.00% | -100.0% |
Q3 2017 | $1,600,000 | -80.2% | 79,961 | -81.9% | 0.00% | -75.0% |
Q2 2017 | $8,089,000 | +25.7% | 441,473 | -32.5% | 0.00% | +33.3% |
Q1 2017 | $6,434,000 | +127.7% | 653,901 | +152.4% | 0.00% | +50.0% |
Q4 2016 | $2,826,000 | -56.9% | 259,023 | -44.6% | 0.00% | -50.0% |
Q3 2016 | $6,552,000 | +133.7% | 467,619 | +17.1% | 0.00% | +100.0% |
Q2 2016 | $2,803,000 | +31.5% | 399,168 | +20.5% | 0.00% | +100.0% |
Q1 2016 | $2,132,000 | -2.5% | 331,243 | +391.2% | 0.00% | 0.0% |
Q4 2015 | $2,186,000 | +1.4% | 67,432 | -16.4% | 0.00% | 0.0% |
Q3 2015 | $2,155,000 | -50.5% | 80,694 | -10.8% | 0.00% | -50.0% |
Q2 2015 | $4,354,000 | -0.4% | 90,484 | +26.0% | 0.00% | -33.3% |
Q1 2015 | $4,371,000 | +51.2% | 71,817 | +28.7% | 0.00% | +50.0% |
Q4 2014 | $2,890,000 | +90.6% | 55,812 | +62.0% | 0.00% | +100.0% |
Q3 2014 | $1,516,000 | -6.1% | 34,442 | -44.2% | 0.00% | 0.0% |
Q2 2014 | $1,614,000 | – | 61,757 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |